GeneScience Pharmaceuticals Co., Ltd.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. - Product<br />
Pipeline Review – 2015 Now Available at iData Insights<br />
<strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. - Product Pipeline Review - 2015 Summary Global Markets Direct<br />
s, <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. - Product Pipeline Review - 2015 , provides an overview of the<br />
<strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. s pharmaceutical research and development focus.<br />
This report provides comprehensive information on the current therapeutic developmental pipeline of<br />
<strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>.s, complete with comparative analysis at various stages,<br />
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and<br />
molecule type. It also reviews latest updates, and featured news and press releases, along with special<br />
features on late-stage and discontinued projects. Global Markets Directs report features investigational<br />
drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built<br />
using data and information sourced from Global Markets Directs proprietary databases,<br />
<strong>Co</strong>mpany/University websites, SEC filings, investor presentations and featured press releases from<br />
company/university sites and industry-specific third party sources, put together by Global Markets<br />
Direct s team.<br />
Drug profiles/records featured in the report undergoes periodic updation following a stringent set of<br />
processes that ensures that all the profiles are updated with the latest set of information. Additionally,<br />
processes including live news & deals tracking, browser based alert-box and clinical trials registries<br />
tracking ensure that the most recent developments are captured on a real time basis. The report<br />
enhances decision making capabilities and help to create effective counter strategies to gain<br />
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce<br />
first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered<br />
based on the availability and relevance of data for the indicated disease. Scope - The report provides<br />
brief overview of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. including business description, key information<br />
and facts, and its locations and subsidiaries - The report reviews current pipeline of <strong>GeneScience</strong><br />
<strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>.s human therapeutic division and enlists all their major and minor projects -<br />
The report features product description and descriptive mechanism of action for key pipeline products<br />
along with the product s developmental history and major milestones - Special feature on out-licensed<br />
and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline<br />
projects - Latest company statement - Latest news and deals relating to the <strong>GeneScience</strong><br />
<strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. s pipeline products Reasons to buy - Evaluate <strong>GeneScience</strong> <strong>Pharmaceuticals</strong><br />
<strong>Co</strong>., <strong>Ltd</strong>. s strategic position with total access to detailed information on its product pipeline - Assess the<br />
growth potential of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. in its therapy areas of focus - Identify new<br />
drug targets and therapeutic classes in the <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. s R&D portfolio and<br />
develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by<br />
identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding<br />
the focus areas of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. and exploit collaboration and partnership<br />
opportunities - Identify emerging players with potentially strong product portfolio and create effective<br />
counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by<br />
identifying the most promising pipeline of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. - Develop and design<br />
in-licensing and out-licensing strategies by identifying prospective partners with the most attractive<br />
1
projects to enhance and expand business potential and scope - Explore the dormant and discontinued<br />
projects of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. and identify potential opportunities in those areas -<br />
Avoid Intellectual Property Rights related issues<br />
Browse <strong>Co</strong>mplete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015<br />
To Get Sample <strong>Co</strong>py of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015<br />
Table of <strong>Co</strong>ntents<br />
Table of <strong>Co</strong>ntents 2<br />
List of Tables 4<br />
List of Figures 4<br />
<strong>GeneScience</strong> Pharmaceutical AB Snapshot 5<br />
<strong>GeneScience</strong> Pharmaceutical AB Overview 5<br />
Key Information 5<br />
Key Facts 5<br />
<strong>GeneScience</strong> Pharmaceutical AB - Research and Development Overview 6<br />
Key Therapeutic Areas 6<br />
NeuroVive Pharmaceutical AB - Pipeline Review 8<br />
Pipeline Products by Stage of Development 8<br />
Pipeline Products - Monotherapy 9<br />
Pipeline Products - Out-Licensed Products 10<br />
Out-Licensed Products/<strong>Co</strong>mbination Treatment Modalities 11<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products Glance 12<br />
<strong>GeneScience</strong> Pharmaceutical AB - Late Stage Pipeline Products 12<br />
Phase III Products/<strong>Co</strong>mbination Treatment Modalities 12<br />
<strong>GeneScience</strong> Pharmaceutical AB - Clinical Stage Pipeline Products 13<br />
Phase II Products/<strong>Co</strong>mbination Treatment Modalities 13<br />
<strong>GeneScience</strong> Pharmaceutical AB - Early Stage Pipeline Products 14<br />
Preclinical Products/<strong>Co</strong>mbination Treatment Modalities 14<br />
2
Discovery Products/<strong>Co</strong>mbination Treatment Modalities 15<br />
<strong>GeneScience</strong> Pharmaceutical AB - Drug Profiles 16<br />
cyclosporine 16<br />
Product Description 16<br />
Mechanism of Action 16<br />
R&D Progress 16<br />
NVP-014 19<br />
Product Description 19<br />
Mechanism of Action 19<br />
R&D Progress 19<br />
NVP-019 20<br />
Product Description 20<br />
Mechanism of Action 20<br />
R&D Progress 20<br />
NVP-015 21<br />
Product Description 21<br />
Mechanism of Action 21<br />
R&D Progress 21<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Analysis 22<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products by Target 22<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products by Route of Administration 23<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products by Molecule Type 24<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products by Mechanism of Action 25<br />
<strong>GeneScience</strong> Pharmaceutical AB - Recent Pipeline Updates 26<br />
<strong>GeneScience</strong> Pharmaceutical AB - Dormant Projects 29<br />
<strong>GeneScience</strong> Pharmaceutical AB - Discontinued Pipeline Products 30<br />
3
Discontinued Pipeline Product Profiles 30<br />
cyclosporine 30<br />
<strong>GeneScience</strong> Pharmaceutical AB - Locations And Subsidiaries 31<br />
Head Office 31<br />
Other Locations & Subsidiaries 31<br />
Appendix 32<br />
Methodology 32<br />
<strong>Co</strong>verage 32<br />
Secondary Research 32<br />
Primary Research 32<br />
Expert Panel Validation 32<br />
<strong>Co</strong>ntact Us 32<br />
Disclaimer 33<br />
Read More http://www.idatainsights.com/reports-landing-page.php?id=124226/neurovivepharmaceutical-ab-product-pipeline-review-2015<br />
About Us:<br />
iData Insights which operates under Precision Research and <strong>Co</strong>nsulting Private Limited is a leading<br />
market research information aggregator and marketing research consulting firm. We conduct both<br />
primary and secondary research. Our work does not end with research it is also involved in distributing<br />
reports for different companies . We provide actionable recommendations and provide our expertise for<br />
business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and<br />
discovery, and then be their guide in the implementation of changes that will make a difference to their<br />
bottom line.<br />
<strong>Co</strong>ntactUs:<br />
iData Insights<br />
Tel: 1-866-237-2965<br />
Web: http://www.idatainsights.com<br />
Email: info@idatainsights.com<br />
About iData Insights<br />
We work around the clock until our clients are completely satisfied with their promised results. It is our<br />
mission to provide timely services coupled with acute client care to create a long-lasting relationship<br />
with you. We deliver on our promise to provide results that are essential to the success of your<br />
company. We believe that by doing so, we will earn the trust of our clients for future projects<br />
4
Change language